KUALA LUMPUR (Sept 17): The National Covid-19 Immunisation Programme (PICK) budget should be raised to RM6.
KUALA LUMPUR (Aug 27): The decision to halt the involvement of private general practitioners in the National Covid-19 Immunisation Programme (PICK) in the Klang Valley is only temporary.
KUALA LUMPUR (Aug 15): The National Covid-19 Immunisation Programme (PICK) is on track to achieve its target of getting 50% of Malaysia's adult population fully vaccinated in the month of August, according to its coordinating minister Khairy Jamaluddin.
Political crisis will not affect implementation of public health programme in Penang, says chief minister
NIBONG TEBAL (Aug 15): The Penang government will not allow the current political crisis in the country to affect the public health programme being actively implemented in the state.
KUALA LUMPUR (Aug 15): The National Covid-19 Immunisation Programme (PICK) has shown early positive developments with a drop in infections in Categories 3 to 5 in six states, said Prime Minister Tan Sri Muhyiddin Yassin.
PUTRAJAYA (Aug 2): Walk-in vaccination for senior citizens aged 60 and above will be extended throughout the country from next week, said National Covid-19 Immunisation Programme (PICK) Coordinating Minister Khairy Jamaluddin.
KUALA LUMPUR (July 20): Sungai Buloh Hospital’s latest data until Sunday, July 18 indicated a drastic drop in serious infection case admissions (Category Four and Five) among the elderly from the 23rd epidemiological week (EW).
KUALA LUMPUR (June 27): The number of Covid-19 vaccine jabs declined to 187,877 doses yesterday, from 215,968 doses on Friday (June 25).
KUALA LUMPUR (June 24): The private sector vaccination programme in the country is expected to start in August, said Coordinating Minister of the National Covid-19 Immunisation Programme Khairy Jamaluddin.
KUALA LUMPUR (June 22): Malaysia administered 235,623 doses of Covid-19 vaccines yesterday (June 21), the highest daily number since the beginning of the vaccine roll-out in March, according to latest data from the Covid-19 Vaccine Supply Access Guarantee Special Committee (JKJAV).